Pharma channel feed

San­thera gears up for EU launch of va­morolone in Duchenne af­ter pos­i­tive CHMP opin­ion

Last year

Flag­ship Pi­o­neer­ing re­casts its cor­po­rate brand with ‘Big­ger Leaps’ tagline and am­bi­tion

Last year
Marketing

More than 'just a rash': In­cyte taps Mandy Moore in atopic der­mati­tis cam­paign

Last year
Marketing

Qual­i­ty con­sid­er­a­tions for top­i­cal eye treat­ments: FDA pub­lish­es new draft guid­ance

Last year
FDA+

How an earn­ings call com­ment from Al San­drock pro­pelled an ap­peals court's re­ver­sal on a Bio­gen in­vestor suit

Last year
Law

FDA’s drug pro­mo­tion watch­dog plans study around ad­her­ence claims in phar­ma ads

Last year
Marketing

GSK looks to au­tho­rized gener­ic ver­sion of asth­ma treat­ment as Med­ic­aid re­bate caps lift next year

Last year
FDA+

Pfiz­er ex­pands la­bel for block­buster BRAF/MEK com­bo in­to lung can­cer

Last year

BioN­Tech sends $70M to an­oth­er ADC part­ner to go up against Dai­ichi Sankyo in HER3

Last year
Deals
China

Delaware judge ap­proves Mallinck­rodt's sec­ond bank­rupt­cy plan since 2020

Last year

Bio­gen cuts al­most one-third of Reata's staff fol­low­ing $7B buy­out

Last year
People

Su­per­nus drafts NFL sports­cast­er in me­dia and so­cial blitz for AD­HD med Qel­bree

Last year
Marketing

GSK set­tles an­oth­er heart­burn drug Zan­tac can­cer case in Cal­i­for­nia, does­n't ad­mit li­a­bil­i­ty

Last year
Law

CMS post­pones na­tion­al cov­er­age de­ter­mi­na­tion for PrEP, says de­ci­sion is 'forth­com­ing'

Last year
FDA+

Sanofi and Har­ris Poll glob­al he­mo­phil­ia study finds ‘trou­bling dis­con­nect’ be­tween pa­tients and providers

Last year
Marketing

Mod­er­na's new Covid-19 vac­cine analy­sis 'giv­ing weight' to an­nu­al boost­ing in­ter­val, com­pa­ny says

Last year
Coronavirus

CRO at cen­ter of Pfiz­er’s Ly­me vac­cine study woes says FDA found no tri­al mis­con­duct 

Last year
R&D
FDA+

FDA hits New Jer­sey API man­u­fac­tur­er with 14 de­fi­cien­cies across three sites in Form 483

Last year
FDA+
Manufacturing

Al­most a year since Hu­mi­ra biosim­i­lars launched, Ab­b­Vie still con­trols more than 97% of the US mar­ket

Last year

Em­ploy­ers cov­er­ing GLP-1s could dou­ble in 2024 as ques­tions over cov­er­age guardrails loom

Last year
FDA+

Pfiz­er cuts jobs at Boul­der, CO, re­search fa­cil­i­ty

Last year
People

No­vavax de­buts Covid vac­ci­na­tion cam­paign with celebri­ty spokesper­son as mil­lions of US dos­es ship

Last year
Marketing

Mar­ket­ingRx roundup: Phar­ma brands get cre­ative on In­sta­gram; J&J re­ups health eq­ui­ty chal­lenge

Last year
Marketing

How CVS and Wal­greens are be­com­ing phar­ma’s new big ad­ver­tis­ing strat­e­gy

Last year
Marketing
First page Previous page 979899100101102103 Next page Last page
A service from the Financial Times